OVERVIEW

Role of Immunotherapy in the Era of Precision Medicine is organized by Society for Translational Oncology (STO).

Released: 5/11/2021 
Expires: 5/11/2022 

Target Audience
Physicians who wish to advance their current knowledge of targeting MET in cancer treatment.

Learning Objectives:
• To understand MET exon 14 skipping and MET amplification as biomarkers in lung cancer?
• To review currently available evidence for MET TKIs in the treatment of MET altered lung cancers?
• To assess current knowledge of resistance mechanisms to MET directed therapy

Credits
  • 0.5 AMA PRA Category 1 Credit™
  • TARGET AUDIENCE

    Physician

    SPECIALITIES

    Oncology

    RELATED ONLINE COURSES